SLNSW-Efficacy and safety of radium-223 dichloride in p...-TN_cdi_swepub_primary_oai_prod_swepub_kib_ki_se_130109471

Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial

Full title: Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial

Author/creator: Hoskin, Peter, Prof, Sartor, Oliver, Prof, O'Sullivan, Joe M, Prof, Johannessen, Dag Clement, MD, Helle, Svein I, MD, Logue, John, FRCR, Bottomley, David, FRCR, Nilsson, Sten, Prof, Vogelzang, Nicholas J, Prof, Fang, Fang, PhD, Wahba, Mona, MD, Aksnes, Anne-Kirsti, PhD, Parker, Christopher, MD.

Call Numbers:

Record Identifier: TN_cdi_swepub_primary_oai_prod_swepub_kib_ki_se_130109471

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_prod_swepub_kib_ki_se_130109471

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial

    Record identifier

    TN_cdi_swepub_primary_oai_prod_swepub_kib_ki_se_130109471

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_prod_swepub_kib_ki_se_130109471

    Share

    Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_prod_swepub_kib_ki_se_130109471

    Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial

    Full title

    Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial

    Author / Creator

    Hoskin, Peter, Prof ; Sartor, Oliver, Prof ; O'Sullivan, Joe M, Prof ; Johannessen, Dag Clement, MD ; Helle, Svein I, MD ; Logue, John, FRCR ; Bottomley, David, FRCR ; Nilsson, Sten, Prof ; Vogelzang, Nicholas J, Prof ; Fang, Fang, PhD ; Wahba, Mona, MD ; Aksnes, Anne-Kirsti, PhD ; Parker, Christopher, MD

    Publisher

    England: Elsevier Ltd

    Journal title

    The lancet oncology, 2014, Vol.15 (12), p.1397-1406

    Record Identifier

    TN_cdi_swepub_primary_oai_prod_swepub_kib_ki_se_130109471

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Aged Aged, 80 and over Analysis Antimitotic agents Antineoplastic agents Blood platelets Bone Neoplasms - drug therapy Bone Neoplasms - radiotherapy Bone Neoplasms - secondary Cancer therapies Care and treatment Cells Chemotherapy Clinical trials Combined Modality Therapy Cytotoxicity Docetaxel Double-Blind Method Drug therapy Hematology Hematology, Oncology and Palliative Medicine Humans Kaplan-Meier Estimate Male Medicin och hälsovetenskap Metastasis Middle Aged Pain Product development Prostate cancer Prostatic Neoplasms, Castration-Resistant - drug therapy Prostatic Neoplasms, Castration-Resistant - pathology Prostatic Neoplasms, Castration-Resistant - radiotherapy Radiation therapy Radioisotopes - administration & dosage Radioisotopes - adverse effects Radium - administration & dosage Radium - adverse effects Regulatory approval Taxoids - administration & dosage

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_swepub_primary_oai_prod_swepub_kib_ki_se_130109471

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_prod_swepub_kib_ki_se_130109471

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    About resource >

    View in old catalogue

    Connecting people and collections